Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

MyDietDoc vs myRocky

MyDietDoc
Graded #464

Higher grade

vs+2.200000000000003
myRocky
Graded #487

Lower grade

The verdict

MyDietDoc takes it — 53.6/100 to 51.4/100.

MyDietDoc grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MyDietDoc (mydietdoc.com, also operating as dietdoc.com) is an established US telehealth practice based in Oracle, Arizona that prescribes GLP-1 weight-loss medication among other treatments.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMyDietDoc +11
45
34
Dose & formulationmyRocky +13
40
53
Clinical oversightMyDietDoc +9
73
64
Labs & monitoringEven
52
52
FulfillmentmyRocky +7
63
70
Contract termsMyDietDoc +14
55
41
MyDietDoc · left barmyRocky · right bar

The numbers

MetricMyDietDocmyRocky
WeighScore53.6/10051.4/100
GradeCC
Scorecard rank#464#487
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
MyDietDoc

Graded #464 · C

Strengths

  • Established physician-run telehealth with phone and email support
  • States medications are compounded by licensed US 503A pharmacies

Where it loses points

  • No pricing published on the public site
  • Service-area states not listed
  • No specific compounding pharmacy or named physicians on the public pages
myRocky

Graded #487 · C

Strengths

  • Brand-name FDA-approved GLP-1s (Ozempic, Mounjaro, Wegovy) on one platform — no compounded-product risk
  • LegitScript Approved
  • 42-state coverage with an 8-state expansion roadmap published
  • Multi-product platform for patients managing GLP-1 plus sexual health, hair loss, or mental health on one subscription

Where it loses points

  • Expensive stacked fees: $99 consult + $99/mo program fee + ~$1,409/mo medication = ~$1,508/mo
  • Canadian incorporation (Rocky Health Inc., Mississauga, ON) — verify your state's prescriber holds an active US license
  • Listed pharmacy is a Canadian community pharmacy; US-fulfillment supply chain not transparent
  • Brand-only — no compounded option for cost-sensitive patients
  • $1,409/mo Ozempic is near retail; compare NovoCare ($349/mo Wegovy pen) or LillyDirect ($449–$699/mo Zepbound)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard